Sort by:
28 products
28 products
Azulfidine (Sulfasalazine) 500 mg
Active ingredient: Sulfasalazine
Concentration: 500 mg per tablet
Presentation: Box with 60 tablets
Laboratory: Pfizer
Origin: Made in Mexico
This medication is used for the treatment of chronic inflammatory diseases such as ulcerative colitis and rheumatoid arthritis. It acts through an immunomodulatory mechanism that reduces inflammation in the intestine and joints, controlling symptoms and preventing the progression of these autoimmune diseases.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
SALOFALK (Mesalazine) 500mg 40tablets
Comparable to: Asacol
Active ingredient: MESALAZINE
Concentration: 500mg
Presentation: 40tablets
Laboratory: SCHWABE
Origin: Made in Mexico
Mesalazine is an intestinal anti-inflammatory that acts directly on the colon lining, reducing local inflammation. It is used for the treatment of ulcerative colitis and Crohn's disease in active phases or for maintaining remission. It helps relieve symptoms such as abdominal pain, diarrhea, rectal bleeding, and urgency, contributing to digestive health and quality of life.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
LIBERTRIM
Comparable to: Libertrim
Active ingredient: Trimebutine
Concentration: 200MG
Presentation: 48 TABLETS
Laboratory: CARNOT
Origin: Made in Mexico
Libertrim contains trimebutine, a gastrointestinal motility regulator that relieves abdominal pain and discomfort. It works by normalizing the movements of the digestive tract, being useful for treating irritable bowel syndrome, dyspepsia, and associated constipation or diarrhea. It improves digestive function and reduces spasms.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
ESPABION
Comparable to: Liberan
Active ingredient: TRIMEBUTINE
Concentration: 2 g / 100 ml
Presentation: PEDIATRIC DROPS 30ML
Laboratory: DEGORT S CHEMICAL
Origin: Made in Mexico
Espabion Pediatric, with trimebutine, is a gastrointestinal motility regulator designed for infants and children. It relieves colic, reflux, abdominal distension, and other functional digestive disorders. It works by normalizing intestinal movements, which reduces pain and improves digestion, providing comfort to little ones.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before taking any medication.
OMURO
Comparable to: Debromu
Active ingredient: OTILONIUM BROMIDE
Concentration: 40 MG
Presentation: 15 TABLETS
Laboratory: SANFER
Origin: Made in Mexico
Omuro contains otilonium bromide, a musculotropic antispasmodic that acts selectively on the smooth muscle of the gastrointestinal tract. It is indicated for the treatment of irritable bowel syndrome, relieving pain, spasms, and abdominal distension. It helps regulate intestinal motility and reduce digestive discomfort.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
METEOSPASMYL
Comparable to: Meteospasmyl
Active ingredient: ALVERINE, SIMETHICONE
Concentration: 60MG, 300MG
Presentation: 20 CAPSULES
Laboratory: MAYOLY SPINDLER
Origin: Made in Mexico
Meteospasmyl is a medication that effectively relieves pain, bloating, and discomfort associated with irritable bowel syndrome. Alverine acts as a direct antispasmodic on intestinal smooth muscle, while simethicone disperses trapped gases. This combination reduces abdominal pain and distension, improving digestive comfort.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
NESAJAR
Comparable to: Alevian
Active ingredient: PINAVERIUM/DIMETHICONE
Concentration: 100MG 300MG
Presentation: 32 CAPSULES
Laboratory: GELPHARMA
Origin: Made in Mexico
Nesajar is a combination that relieves symptoms of irritable bowel syndrome (IBS) such as pain, bloating, and abdominal discomfort. Pinaverium relaxes intestinal smooth muscles, reducing spasms, while dimethicone acts as an antiflatulent, dispersing gases. It provides comprehensive relief for intestinal dysfunction.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Bipasmin Compound N 10 mg / 250 mg
Comparable to: Buscapina Compositum
Active ingredient: Butylscopolamine / Metamizole
Concentration: 10 mg / 250 mg
Presentation: Dragees
Laboratory: Boehringer
Origin: Mexico
This medication is used for the relief of colicky pain and spasms of the gastrointestinal, biliary, or urinary tract, combining the antispasmodic action of butylscopolamine with the analgesic effect of metamizole.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
CARNOTPRIM (METOCLOPRAMIDE) 10 mg
Comparable to: Carnotprim
Active substance: Metoclopramide
Concentration: 10 mg per tablet
Presentation: Box with 20 tablets
Laboratory: Carnot
Origin: Mexico
This medication is used for the treatment of nausea and vomiting of various causes, as well as in the management of gastrointestinal motility disorders, as metoclopramide helps to accelerate stomach emptying and promotes intestinal movement.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
Gastrointestinal Disorders: gastroesophageal reflux, infectious gastroenteritis, gastric ulcer, pyloric stenosis, chronic primitive intestinal pseudo-obstructions.
Iatrogenic gastroparesis: To counteract the effects of the use of anticholinergics, opiates, dopaminergics.
Surgical sequelae: Vagotomy with pyloroplasty, fundic vagotomy, partial gastrectomies.
Psychic and neuromuscular disorders: Anorexia nervosa, amyloidosis, collagenopathies, scleroderma, muscular dystrophies (spastic colon), various neuropsychiatric syndromes.
Metabolic and endocrine disorders: diabetes, hypothyroidism, renal failure.
In acute or chronic vomiting, of gastroenterological, infectious, metabolic, endocrine, neurological, iatrogenic, psychogenic, anatomical, respiratory etiology.
Prophylactic utility in nausea and/or vomiting caused by: Chemotherapy, radiotherapy, perianesthesia, motion sickness, etc.
Of analgesic utility due to central action (alone or in interaction): As an aid in headaches of vascular origin (migraine).
Useful in the induction of lactation. An aid when lactation needs to be induced.
CONTRAINDICATIONS: Hypersensitivity to metoclopramide. Intestinal obstruction, perforation, or any other condition in which increased gastrointestinal motility is risky. Acute appendicitis, extrapyramidal syndrome.
GENERAL PRECAUTIONS: When metoclopramide is administered concomitantly with psychotropics, antihistamines, or barbiturates, it should be noted that it may produce additional depressive effects on the CNS, likewise when alcohol is consumed concomitantly with the medication.
When the parenteral route is used, if the medication is administered rapidly, extrapyramidal symptoms (torticollis, trismus, oculogyric crises) may occur, which are reversible upon discontinuation of the medication or subside with the administration of diazepam or diphenhydramine. In international literature, the appearance of extrapyramidal symptoms with the administration of metoclopramide at therapeutic doses is 1 in 33,000 patients.
In patients with chronic renal failure, the administration of the drug for prolonged periods should be evaluated, because its elimination is renal in 98% of cases, and if necessary, the dose of the medication will be adjusted.
RESTRICTIONS ON USE DURING PREGNANCY AND LACTATION: Metoclopramide has been widely used during pregnancy to relieve hyperemesis gravidarum, gastroesophageal reflux, and gastroparesis that may occur during pregnancy.
The general consensus recommends its use during the second and third trimesters of pregnancy, and as with the vast majority of medications not contraindicated during pregnancy, its prescription during the first trimester is left to the discretion of the treating physician, taking into account the severity of the case, the potential benefits and the probable risk that there might be for the product.
Metoclopramide is eliminated in small doses in breast milk (see Dosage and Administration).
CARNOTPRIM Tablets 10 mg: (gastroprokinetic, antiemetic, gastroesophageal reflux, anti-migraine).
Children 6 to 12 years: ½ tablet (5 mg) 3 times daily before meals.
Over 12 years or over 40 kg:
1 tablet 3 or 4 times daily before meals.
CARNOTPRIM Tablets 10 mg: (gastroprokinetic, antiemetic, anti-migraine, assist in the induction of lactation).
Adults and children over 40 kg: 1 tablet 3 or 4 times daily before meals.
Induction of lactation: 1 tablet every 8 hours, depending on the response of the patient, for a maximum period of 10 days.
CIRULAN (METOCLOPRAMIDE) 10 mg
Comparable to: Cirulan
Active ingredient: Metoclopramide
Concentration: 10 mg per tablet
Presentation: Box with 20 tablets
Laboratory: Novag
Origin: Mexico
This medication is used for the treatment of nausea and vomiting of various causes, as well as in the management of gastrointestinal motility disorders, as metoclopramide helps to accelerate stomach emptying and promotes intestinal movement.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Gastrointestinal Disorders: gastroesophageal reflux, infectious gastroenteritis, gastric ulcer, pyloric stenosis, chronic intestinal pseudo-primitive.
Iatrogenic gastroparesis: To counteract the effects of the use of anticholinergics, opiates, dopamine.
Surgical sequelae: Vagotomy with pyloroplasty fundic vagotomy, partial gastrectomy.
Psychic and neuromuscular disorders: Anorexia nervosa, amyloidosis, collagen diseases, scleroderma, muscular dystrophy (spastic colon), various neuropsychiatric syndromes.
Metabolic and endocrine disorders: diabetes, hypothyroidism, renal failure.
In acute or chronic vomiting, etiology, gastroenterology, infectious, metabolic, endocrine, neurological, iatrogenic, psychogenic, anatomical breathing.
Prophylactic utility nausea and / or vomiting from chemotherapy, radiotherapy, PeriAnesthesia, travel sickness, etc..
Useful for centrally acting analgesic (alone or in interaction): As an aid in vascular headaches (migraine).
Useful in the induction of lactation. Assistant when required to induce lactation.
Hypersensitivity to metoclopramide. Intestinal obstruction, perforation or any other condition in which increased gastrointestinal motility is risky. Acute appendicitis, extrapyramidal syndrome.
CAUTIONS: When administered metoclopramide in conjunction with psychotropic drugs, antihistamines, or barbiturates, it should be noted that additional depressive effect may occur in the CNS, also when alcohol is consumed concurrently with the drug.
When you use the injectors, if the medicine is applied quickly can even cause extrapyramidal symptoms (torticollis, trismus, oculogyric crisis), which are reversible after discontinuation of the drug or give in to the administration of diazepam or diphenhydramine. In the international literature, the emergence of extrapyramidal symptoms with metoclopramide at therapeutic doses is 1 in 33,000 patients.
In patients with chronic renal failure should be evaluated drug administration for prolonged periods, because their elimination is via the kidneys in 98% and, if necessary, adjust the dose of medication.
DOSAGE AND ADMINISTRATION: Oral.
CARNOTPRIM Tablets 10 mg (gastroprokinetic, antiemetic, gastroesophageal reflux disease, migraine).
Children 6 to 12 years: ½ tablet (5 mg) 3 times daily before meals.
Over 12 years or over 40 kg:
1 tablet 3 or 4 times daily before meals.
CARNOTPRIM Tablets 10 mg (gastroprokinetic, antiemetics, antimigraine, assist in the induction of lactation).
Adults and children over 40 kg: 1 tablet 3 or 4 times daily before meals.
Induction of lactation: 1 tablet every 8 hours, depending on the response of the patient, for a maximum period of 10 days
MOTILIUM (DOMPERIDONE) 10 mg
Comparable to: Motilium
Active ingredient: Domperidone
Concentration: 10 mg per tablet
Presentation: Box with 30 tablets
Laboratory: JANSSEN-CILAG
Origin: Mexico
This medicine is used for the treatment of nausea, vomiting, and symptoms of slow gastrointestinal motility (such as feeling of fullness, bloating, and post-prandial discomfort). Domperidone works by increasing stomach and intestinal movement, facilitating digestion and reducing nausea.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
- Feeling at epigastric fullness, early satiety, feeling of abdominal distention, upper abdominal pain.
- Belching, flatulence.
- Nausea and vomiting.
- Heartburn with or without regurgitation of gastric contents into the mouth.
- Nausea and vomiting of functional origin, organic, infectious or dietetic or induced by radiation therapy or pharmacotherapy.
A specific indication is nausea and vomiting induced by dopamine agonists, such as those used in Parkinson's disease (such as L-dopa and bromocriptine).
CONTRAINDICATIONS: Motilium ® is contraindicated in the following situations:
Known hypersensitivity to domperidone or any of its excipients.
Prolactin-releasing pituitary tumor (prolactinoma).
Coadministration with oral ketoconazole, erythromycin, or other potent CYP3A4 inhibitors that prolong the QTc interval such as fluconazole, voriconazole, clarithromycin, amiodarone, and telithromycin.
Motilium ® should not be used in cases in which the stimulation of gastric motility might be dangerous, for example, gastrointestinal hemorrhage, mechanical obstruction or perforation.
CAUTIONS: When using antacids or antisecretory agents, concomitantly, they should be administered after meals and not before them, ie should not be administered simultaneously with the tablets and suspension Motilium ®.
Use Precautions: Enteric coated tablets contain lactose and may be unsuitable for patients with lactose intolerance, galactosemia, or malabsorption of glucose / galactose.
The oral suspension contains sorbitol and may be inadequate for patients intolerant to sorbitol.
Use in children: Because the metabolic and blood-brain barrier are not fully developed during the first months of life, Motilium ® as well as any medication that is administered to infants younger, should be used with caution and under close supervision care.
Since the typical absence of neurological side effects Motilium ® is due to the limited penetration through the blood brain barrier, the occurrence of these effects can not be totally excluded in babies under 1 year.
Use in hepatic impairment: Since domperidone is extensively metabolized in the liver, Motilium ® should be used with caution in patients with liver damage.
Use in renal impairment: In patients with severe renal insufficiency (serum creatinine> 6 mg/100 ml, for example,> 0.6 mmol / l) elimination half-life of domperidone is increased from 7.4 to 20.8 hours but plasma levels are lower than in healthy volunteers. Since a small amount of the drug is excreted by the kidneys, it is unlikely that the dose of a single acute dose needs to be adjusted in patients with renal failure. However, with repeated administration, frequency of administration should be reduced to once or twice daily depending on the severity of damage, and may also be necessary to reduce the dose.
Generally, patients with prolonged therapy should be reviewed regularly.
Effects on ability or use machines: Motilium ® does not affect mental alertness.
RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION:
Use in pregnancy: There are limited post-marketing data on the use of domperidone in pregnant women. A study in rats has shown reproductive toxicity at high doses, is toxic to the mother. No one knows the potential risk to humans. Therefore, Motilium ® should be used during pregnancy only where justified by the anticipated therapeutic benefit.
Adults and adolescents (over 12 years and weighing 35 kg or more):
Tablets: 1 to 2 tablets of 10 mg three to four times a day, with a maximum daily dose of 80 mg.
ESPACIL COMPUESTO 125 mg / 10 mg 20 TAB
Comparable to: Espacil Compuesto
Active ingredient: Clonixinate lysine / Hyoscine butylbromide
Concentration: 125 mg / 10 mg
Presentation: Tablets
Laboratory: Laboratorios Grossman
Origin: Mexico
This medicine combines a non-narcotic analgesic (clonixinate lysine) with an antispasmodic (hyoscine butylbromide) to relieve pain and spasms associated with renal, ureteral or bladder colic, dysmenorrhea (menstrual pain), and gastrointestinal pain such as cholelithiasis, irritable bowel syndrome, colitis and diverticulitis.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
Prescol 200 mg
Comparable to: Debridat
Active ingredient: Trimebutine
Concentration: 200 mg per tablet
Presentation: Box with 30 tablets
Laboratory: Abbott
Origin: Mexico
This medication is used for the treatment of functional disorders of the digestive system, such as colitis, irritable bowel syndrome, and gastrointestinal spasms, helping to regulate intestinal motility and relieve abdominal pain.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Onoton
Comparable to: Onoton
Active ingredient: Pancreatin / Hemicellulase / Simethicone
Presentation: Box with 50 tablets
Laboratory: Kendrick
Origin: Mexico
This medication is used as an aid in the treatment of digestive disorders, helping to improve food digestion, reduce abdominal bloating, and relieve gas and stomach heaviness.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.

{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>